Our understanding of inherited risk factors for colorectal cancer (CRC) is incomplete. A new study reports the identification of germline CRC risk variants that adversely affect the proofreading function of DNA polymerases encoded by POLE and POLD1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
05 September 2013
In the version of the article initially published, reference 6 (J. Biol. Chem. 281, 4486–4494, 2006) should have been Genome 49, 403–410, 2006. Part of the associated sentence, "Alteration of this amino acid has been shown to lead to mutator phenotypes in yeast6," was revised to "Alteration of the equivalent residue in a related polymerase, POLD1, leads to mutator phenotypes in yeast6." In paragraph 4, alteration of a POLD1 residue in yeast, given as arginine, should have been asparagine. A sentence with an error in paragraph 7, "Similarly, tumors reported by Palles et al.4 that carried the POLE p.Leu424Val exonuclease-deficient germline variant also carried APC alterations," has been changed to state that the POLE p.Leu424Val variant alters an amino acid in the active site of the exonuclease domain. The revised sentence reads "Similarly, tumors reported by Palles et al.4 that carried the POLE p.Leu424Val germline variant, which maps to the active site of the exonuclease domain, also carried APC alterations." The legend for Figure 1 has been amended to include "Adapted with permission from ref. 5."
References
Jemal, A. et al. CA Cancer J. Clin. 61, 69–90 (2011).
Fearon, E.R. Annu. Rev. Pathol. 6, 479–507 (2011).
Burt, R. Drug Discov. Today Dis. Mech. 4, 293–300 (2007).
Palles, C. et al. Nat. Genet. 45, 136–144 (2013).
Preston, B.D., Albertson, T.M. & Herr, A.J. Semin. Cancer Biol. 20, 281–293 (2010).
Murphy, K., Darmawan, H., Schultz, A., Fidalgo da Silva, E. & Reha-Krantz, L.J. Genome 49, 403–410 (2006).
Albertson, T.M. et al. Proc. Natl. Acad. Sci. USA 106, 17101–17104 (2009).
TCGA. Nature 487, 330–337 (2012).
Seshagiri, S. et al. Nature 488, 660–664 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author is an employee of Genentech Inc. and holds Roche stocks.
Rights and permissions
About this article
Cite this article
Seshagiri, S. The burden of faulty proofreading in colon cancer. Nat Genet 45, 121–122 (2013). https://doi.org/10.1038/ng.2540
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.2540
This article is cited by
-
Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient
Journal of Human Genetics (2019)
-
Current clinical topics of Lynch syndrome
International Journal of Clinical Oncology (2019)
-
Nucleotide selectivity defect and mutator phenotype conferred by a colon cancer-associated DNA polymerase δ mutation in human cells
Oncogene (2017)
-
Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer
European Journal of Human Genetics (2015)
-
Erratum: The burden of faulty proofreading in colon cancer
Nature Genetics (2013)
